CRISPR-GEMM Pooled Mutagenic Screening Identifies KMT2D as a Major Modulator of Immune Checkpoint Blockade
Guangchuan Wang(Shandong University), Sidi Chen(Yale Cancer Center), Kristin Kim(Yale Cancer Center), Youssef Errami(Yale Cancer Center), Paul Renauer(Yale Cancer Center), Xiaoyun Dai(Yale Cancer Center), Lvyun Zhu(Yale Cancer Center), Zhiyuan Chu(Yale Cancer Center), Lupeng Ye(Zhejiang University), Leilei Niu(Chinese University of Hong Kong), Yaying Du(Yale Cancer Center), Ryan D. Chow(Yale University), Zhigang Bai(Yale Cancer Center), Cun Liao(Yale Cancer Center), Matthew B. Dong(Yale University), Feifei Zhang(Yale Cancer Center), Yujing Cheng(The University of Texas Southwestern Medical Center), Xiaoya Zhang(University of Wisconsin–Madison), Paul Clark(Yale University)
Cited by 143
Related Papers
High-content CRISPR screening
|Nature Reviews Methods Primers|2022|572
New genes as drivers of phenotypic evolution
|Nature Reviews Genetics|2013|441